首页 | 官方网站   微博 | 高级检索  
     


Potential drug–drug interactions of OMBITASVIR,PARITAPREVIR/ritonavir ± DASABUVIR ± ribavirin in clinical practice
Authors:Elena González‐Colominas  María‐Carlota Londoño  Rosa M Morillas  Xavier Torras  Sergi Mojal  Sabela Lens  Dulce López  Adolfo Gallego  Zoe Mariño  Mercè Ardèvol  Neus Pagès  Ricard Solà  Jose A Carrión
Affiliation:1. Pharmacy Department, Hospital del Mar, Parc de Salut Mar, Barcelona, Spain;2. Liver Unit, Hospital Clínic Barcelona, IDIBAPS, CIBERehd, Barcelona, Spain;3. Department of Hepatology, Hospital Germans Trias i Pujol, CIBERehd, Badalona, Spain;4. Department of Gastroenterology, Hospital Santa Creu i Sant Pau, CIBERehd, Barcelona, Spain;5. Biomedical Research Methods Consultant, Hospital del Mar Medical Research Institute (IMIM), Barcelona, Spain;6. Pharmacy Department, Hospital Germans Trias i Pujol, Badalona, Spain;7. Pharmacy Department, Hospital Santa Creu i Sant Pau, Barcelona, Spain;8. Liver Section, Gastroenterology Department, Hospital del Mar, Universitat Autònoma de Barcelona, IMIM, Barcelona, Spain
Abstract:
Keywords:Dasabuvir  Drug–  drug interactions  Hepatitis C virus  Ombitasvir  Paritaprevir  Ritonavir
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司    京ICP备09084417号-23

京公网安备 11010802026262号